Ocuco announces the company’s rebrand to a more contemporary, refined version of its original brand. It is an evolution that reflects the direction of the whole company....
While for many, myopia is an optically corrected inconvenience (1), for an ever-increasing minority, myopia is a factor leading to more severe vision disorders and visual impairment in mid to later life (2). Myopia is a recognized growing health issue in East Asia, where large-scale...
Up to 50% of people in the Northern Hemisphere suffer from Dry Eye Disease (DED), with or without symptoms. These impressive numbers, published in the TFOS DEWS II Report Executive Summary, can be even more substantial. In some populations, DED prevalence was higher and more...
Ocuco Appoints Dermot Walsh as CRO. As Chief Revenue Officer for Ocuco, Dermot will be responsible for all revenue across all business units...
Ransomware is to data as Glaucoma is to Optometry. One steals away data as the other steals away sight. Ransomware, a type of malware that threatens to perpetually block access to a victim’s data unless a ransom is paid, affects everything from small businesses right...
Ocuco has been named as one of Ireland’s Best Managed companies in the Deloitte Best Managed Companies Awards programme....
Ocuco has appointed Dr. Ian Lane, OD, FAAO to the position of US Product Director and Chief Medical Officer, focusing on Ocuco’s flagship product, Acuitas....
Dublin, Ireland - Ocuco are delighted to announce that the addition of an all-new blog section is now live on the company website; embodying our dedication to advancing knowledge and best practice in all eye care and optical industry sectors. Our multinational team of leading Practitioners,...
Ocuco has announced the appointment of long-time optical industry executive Jim McGrann to its global board. McGrann will advise the group on its international growth, with a particular emphasis on guiding its North American strategy....
